These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 35883855)

  • 1. Hyperferritinemia, Low Circulating Iron and Elevated Hepcidin May Negatively Impact Outcome in COVID-19 Patients: A Pilot Study.
    Szabo R; Petrisor C; Bodolea C; Simon R; Maries I; Tranca S; Mocan T
    Antioxidants (Basel); 2022 Jul; 11(7):. PubMed ID: 35883855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Tocilizumab on Inflammation and Iron Metabolism in Critically Ill Patients with COVID-19.
    Szabo R; Petrișor C; Bodolea C; Dobre V; Tranca S; Clichici S; Szabo I; Melinte RM; Mocan T
    Pharmaceutics; 2023 Feb; 15(2):. PubMed ID: 36839968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID-19, Cation Dysmetabolism, Sialic Acid, CD147, ACE2, Viroporins, Hepcidin and Ferroptosis: A Possible Unifying Hypothesis.
    Cavezzi A; Menicagli R; Troiani E; Corrao S
    F1000Res; 2022; 11():102. PubMed ID: 35340277
    [No Abstract]   [Full Text] [Related]  

  • 4. Hepcidin is a useful biomarker to evaluate hyperferritinemia associated with metabolic syndrome.
    Rauber MR; Pilger DA; Cecconello DK; Falcetta FS; Marcondes NA; Faulhaber GAM
    An Acad Bras Cienc; 2019 May; 91(2):e20180286. PubMed ID: 31090790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-invasive methods for iron overload evaluation in dysmetabolic patients.
    Branisso PPF; de Oliveira CPMS; Filho HML; Lima FR; Santos AS; Mancini MC; de Melo ME; Carrilho FJ; Rocha MS; Clark P; Branisso HJP; Cercato C
    Ann Hepatol; 2022; 27(4):100707. PubMed ID: 35477031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammatory anemia-associated parameters are related to 28-day mortality in patients with sepsis admitted to the ICU: a preliminary observational study.
    Jiang Y; Jiang FQ; Kong F; An MM; Jin BB; Cao D; Gong P
    Ann Intensive Care; 2019 Jun; 9(1):67. PubMed ID: 31183575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persisting alterations of iron homeostasis in COVID-19 are associated with non-resolving lung pathologies and poor patients' performance: a prospective observational cohort study.
    Sonnweber T; Boehm A; Sahanic S; Pizzini A; Aichner M; Sonnweber B; Kurz K; Koppelstätter S; Haschka D; Petzer V; Hilbe R; Theurl M; Lehner D; Nairz M; Puchner B; Luger A; Schwabl C; Bellmann-Weiler R; Wöll E; Widmann G; Tancevski I; Judith-Löffler-Ragg ; Weiss G
    Respir Res; 2020 Oct; 21(1):276. PubMed ID: 33087116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Inflammation on Ferritin, Hepcidin and the Management of Iron Deficiency Anemia in Chronic Kidney Disease.
    Ueda N; Takasawa K
    Nutrients; 2018 Aug; 10(9):. PubMed ID: 30150549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The beneficial role of Hepcidin peptide inhibitor in improved the symptoms of COVID-19 in diabetics: anti-inflammatory and potential therapeutic effects.
    Zeinivand M; Jamali-Raeufy N; Zavvari F
    J Diabetes Metab Disord; 2022 Dec; 21(2):1797-1807. PubMed ID: 35812243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dysmetabolic hyperferritinemia is associated with normal transferrin saturation, mild hepatic iron overload, and elevated hepcidin.
    Chen LY; Chang SD; Sreenivasan GM; Tsang PW; Broady RC; Li CH; Zypchen LN
    Ann Hematol; 2011 Feb; 90(2):139-43. PubMed ID: 20721554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein.
    Nemeth E; Valore EV; Territo M; Schiller G; Lichtenstein A; Ganz T
    Blood; 2003 Apr; 101(7):2461-3. PubMed ID: 12433676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum hepcidin concentration in chronic haemodialysis patients: associations and effects of dialysis, iron and erythropoietin therapy.
    Weiss G; Theurl I; Eder S; Koppelstaetter C; Kurz K; Sonnweber T; Kobold U; Mayer G
    Eur J Clin Invest; 2009 Oct; 39(10):883-90. PubMed ID: 19563467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The interplay among iron metabolism, endothelium and inflammatory cascade in dysmetabolic disorders.
    Yegin ZA; İyidir ÖT; Demirtaş C; Suyanı E; Yetkin İ; Paşaoğlu H; İlhan Ç; Sucak GT
    J Endocrinol Invest; 2015 Mar; 38(3):333-8. PubMed ID: 25245337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Change in serum ferritin concentration in experimentally induced anemia of chronic inflammation in dogs.
    Chikazawa S; Nakazawa T; Hori Y; Hoshi F; Kanai K; Ito N; Orino K; Watanabe K; Higuchi S
    J Vet Med Sci; 2013 Nov; 75(11):1419-26. PubMed ID: 23803460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Higher Hepcidin Levels in Adolescents with Obesity Are Associated with Metabolic Syndrome Dyslipidemia and Visceral Fat.
    Rodríguez-Mortera R; Caccavello R; Hermo R; Garay-Sevilla ME; Gugliucci A
    Antioxidants (Basel); 2021 May; 10(5):. PubMed ID: 34065056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Iron overload in congenital haemolytic anaemias: role of hepcidin and cytokines and predictive value of ferritin and transferrin saturation.
    Barcellini W; Zaninoni A; Gregorini AI; Soverini G; Duca L; Fattizzo B; Giannotta JA; Pedrotti P; Vercellati C; Marcello AP; Fermo E; Bianchi P; Cappellini MD
    Br J Haematol; 2019 May; 185(3):523-531. PubMed ID: 30828802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of hepcidin and anemia in early chronic kidney disease.
    Sonkar SK; Singh NK; Sonkar GK; Pandey S; Bhosale V; Kumar A; Usman K
    Saudi J Kidney Dis Transpl; 2019; 30(2):315-324. PubMed ID: 31031367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum hepcidin concentrations correlate with ferritin in patients with inflammatory bowel disease.
    Mecklenburg I; Reznik D; Fasler-Kan E; Drewe J; Beglinger C; Hruz P;
    J Crohns Colitis; 2014 Nov; 8(11):1392-7. PubMed ID: 24825446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased hepcidin levels in preeclampsia: a protective mechanism against iron overload mediated oxidative stress?
    Shaji Geetha N; Bobby Z; Dorairajan G; Jacob SE
    J Matern Fetal Neonatal Med; 2022 Feb; 35(4):636-641. PubMed ID: 32079434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Iron deficiency diagnosed using hepcidin on critical care discharge is an independent risk factor for death and poor quality of life at one year: an observational prospective study on 1161 patients.
    Lasocki S; Lefebvre T; Mayeur C; Puy H; Mebazaa A; Gayat E;
    Crit Care; 2018 Nov; 22(1):314. PubMed ID: 30463596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.